Barbara C. Worst

5.8k total citations
5 papers, 201 citations indexed

About

Barbara C. Worst is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Barbara C. Worst has authored 5 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Barbara C. Worst's work include Histone Deacetylase Inhibitors Research (3 papers), Signaling Pathways in Disease (2 papers) and Peptidase Inhibition and Analysis (2 papers). Barbara C. Worst is often cited by papers focused on Histone Deacetylase Inhibitors Research (3 papers), Signaling Pathways in Disease (2 papers) and Peptidase Inhibition and Analysis (2 papers). Barbara C. Worst collaborates with scholars based in Germany and United States. Barbara C. Worst's co-authors include Johannes Backs, Lorenz Lehmann, Lan Chen, David M. Patrick, Qiang Sun, Hugo A. Katus, Eric N. Olson, Michael M. Kreußer, Stefan M. Pfister and Kun-Wei Liu and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Cellular and Molecular Life Sciences.

In The Last Decade

Barbara C. Worst

5 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara C. Worst Germany	4	162	46	40	25	23	5	201
Rubén Fernández Spain	8	116 0.7×	11 0.2×	38 0.9×	12 0.5×	20 0.9×	16	228
Fernando Cavalcanti Brazil	9	87 0.5×	30 0.7×	9 0.2×	23 0.9×	14 0.6×	19	247
Yaiza Núñez‐Álvarez Spain	8	239 1.5×	13 0.3×	47 1.2×	23 0.9×	30 1.3×	11	314
Steven C. Chen United States	6	303 1.9×	48 1.0×	18 0.5×	21 0.8×	9 0.4×	6	387
Tova Hershkovitz Israel	10	83 0.5×	22 0.5×	22 0.6×	16 0.6×	41 1.8×	16	167
Rana Chakrabarti Canada	5	146 0.9×	17 0.4×	15 0.4×	8 0.3×	25 1.1×	7	227
Tariq Faquih Saudi Arabia	6	72 0.4×	12 0.3×	19 0.5×	17 0.7×	44 1.9×	6	148
Kym Mina Australia	8	73 0.5×	8 0.2×	28 0.7×	19 0.8×	38 1.7×	12	177
Yeo Sia Wey Singapore	7	207 1.3×	14 0.3×	16 0.4×	6 0.2×	10 0.4×	11	429
Chen-Yun Chen Taiwan	10	184 1.1×	37 0.8×	26 0.7×	7 0.3×	20 0.9×	10	256

Countries citing papers authored by Barbara C. Worst

Since Specialization

Citations

This map shows the geographic impact of Barbara C. Worst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara C. Worst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara C. Worst more than expected).

Fields of papers citing papers by Barbara C. Worst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara C. Worst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara C. Worst. The network helps show where Barbara C. Worst may publish in the future.

Co-authorship network of co-authors of Barbara C. Worst

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara C. Worst. A scholar is included among the top collaborators of Barbara C. Worst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara C. Worst. Barbara C. Worst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Tilburg, Cornelis M. van, Ruth Witt, Kristian W. Pajtler, et al.. (2019). INFORM2 exploratory multinational phase I/II combination study of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies: INFORM2 NivEnt.. Journal of Clinical Oncology. 37(15_suppl). TPS10065–TPS10065. 3 indexed citations

2.

Liu, Kun-Wei, Kristian W. Pajtler, Barbara C. Worst, Stefan M. Pfister, & Robert J. Wechsler‐Reya. (2017). Molecular mechanisms and therapeutic targets in pediatric brain tumors. Science Signaling. 10(470). 43 indexed citations

3.

Worst, Barbara C., David Jones, Ivo Buchhalter, et al.. (2016). TB-17A COMPREHENSIVE PAN-CANCER ANALYSIS OF CHILDHOOD MALIGNANCIES. Neuro-Oncology. 18(suppl 3). iii171.3–iii172. 1 indexed citations

4.

Lehmann, Lorenz, et al.. (2013). Histone deacetylase signaling in cardioprotection. Cellular and Molecular Life Sciences. 71(9). 1673–1690. 42 indexed citations

5.

Backs, Johannes, Barbara C. Worst, Lorenz Lehmann, et al.. (2011). Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. The Journal of Cell Biology. 195(3). 403–415. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact